[go: up one dir, main page]

IT1272295B - "HIV VIRUS DEVELOPMENT INHIBITING COMPOUNDS, THEIR PREPARATION AND USES". - Google Patents

"HIV VIRUS DEVELOPMENT INHIBITING COMPOUNDS, THEIR PREPARATION AND USES".

Info

Publication number
IT1272295B
IT1272295B ITRM940405A ITRM940405A IT1272295B IT 1272295 B IT1272295 B IT 1272295B IT RM940405 A ITRM940405 A IT RM940405A IT RM940405 A ITRM940405 A IT RM940405A IT 1272295 B IT1272295 B IT 1272295B
Authority
IT
Italy
Prior art keywords
preparation
hiv virus
inhibiting compounds
development inhibiting
virus development
Prior art date
Application number
ITRM940405A
Other languages
Italian (it)
Inventor
Rosa Alfredo De
Armando Rossi
Original Assignee
Dev Biotechnological Process S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dev Biotechnological Process S filed Critical Dev Biotechnological Process S
Priority to ITRM940405A priority Critical patent/IT1272295B/en
Publication of ITRM940405A0 publication Critical patent/ITRM940405A0/en
Publication of ITRM940405A1 publication Critical patent/ITRM940405A1/en
Application granted granted Critical
Publication of IT1272295B publication Critical patent/IT1272295B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sono descritti composti ciclici di formula generale: (FORMULA I) in cui: A1 e A2 rappresentano qualsiasi imminoacido e possono essere uguali o diversi tra loro; A3 e A4 rappresentano qualsiasi amminoacido idrofobico e possono essere uguali o diversi tra loro; A5 rappresenta un braccio spaziatore di lunghezza compresa tra circa 12 e 21 A, legato covalentemente alle estremità N - terminale di A1 e C - terminale di A4. I composti sono attivi come inibitori dello sviluppo dei virus HIV.Cyclic compounds of general formula are described: (FORMULA I) wherein: A1 and A2 represent any amino acid and can be the same or different from each other; A3 and A4 represent any hydrophobic amino acid and can be the same or different from each other; A5 represents a spacer arm with a length between about 12 and 21 A, covalently tied to the ends N - terminal of A1 and C - terminal of A4. The compounds are active as inhibitors of the development of HIV.

ITRM940405A 1994-06-22 1994-06-22 "HIV VIRUS DEVELOPMENT INHIBITING COMPOUNDS, THEIR PREPARATION AND USES". IT1272295B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITRM940405A IT1272295B (en) 1994-06-22 1994-06-22 "HIV VIRUS DEVELOPMENT INHIBITING COMPOUNDS, THEIR PREPARATION AND USES".

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940405A IT1272295B (en) 1994-06-22 1994-06-22 "HIV VIRUS DEVELOPMENT INHIBITING COMPOUNDS, THEIR PREPARATION AND USES".

Publications (3)

Publication Number Publication Date
ITRM940405A0 ITRM940405A0 (en) 1994-06-22
ITRM940405A1 ITRM940405A1 (en) 1995-12-22
IT1272295B true IT1272295B (en) 1997-06-16

Family

ID=11402609

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM940405A IT1272295B (en) 1994-06-22 1994-06-22 "HIV VIRUS DEVELOPMENT INHIBITING COMPOUNDS, THEIR PREPARATION AND USES".

Country Status (1)

Country Link
IT (1) IT1272295B (en)

Also Published As

Publication number Publication date
ITRM940405A1 (en) 1995-12-22
ITRM940405A0 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
ATE177757T1 (en) IMPROVED IMMUNOGENIC COMPOSITION AGAINST HUMAN GASTRIN 17
DK1200418T3 (en) Nematodicidal trifluorobutene
FI20011851A7 (en) Dispersible tablet containing fluoxetine or its acid addition salt
ITMI932113A1 (en) FUNGICIDE-BASED OLIGOPEPTIDES
FI970825L (en) Pharmaceutical compositions containing bile salt and buffer to increase the bioavailability of the active compound
MXPA03011527A (en) Shampoos with behenyl alcohol.
TR199700803T1 (en) Novel dipeptidic amidines as thrombin-inhibitors.
EP0695171A1 (en) LONOSPHERES CONTAINING GONADOTROPHIN
DE69308010D1 (en) Acid aqueous cleaner compositions
DK0529031T3 (en) Improved thrombin inhibitors
CA2305013A1 (en) Fusion proteins comprising hiv-1 tat and/or nef proteins
NZ335116A (en) Hair composition comprising starch, polyacrylic acid, solvent and water
DE69826684D1 (en) COVALENT-TIED N, O-CARBOXYMETHYLCHITOSAN AND ITS USE
TR200103427T2 (en) Propanoic acid derivatives that inhibit the binding of integrins to their receptors.
TR200000697T2 (en) Substituted 1,2,3,4,5,6-Hexahydro-2,6-Methano-3-Benzazosin-10-OLs, production methods and their use as pharmaceutical preparations.
TR199802670T2 (en) Pesticide tablet form 'lasyonlar'.
CA2129921A1 (en) Stable aqueous solutions of hybrid .alpha.-interferon bdbb
CA2047802A1 (en) Pharmaceutical compositions
IT1272295B (en) "HIV VIRUS DEVELOPMENT INHIBITING COMPOUNDS, THEIR PREPARATION AND USES".
BR9402493A (en) Acid microemulsion composition
CA2015714A1 (en) Stable aqueous formulations of fluorescent whitening agents
BR9713060A (en) Structurally subjected lh-rh analogs, their uses and the pharmaceutical compositions containing them.
IT1235166B (en) PEPTIDES CONTAINING SILICON, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
WO2002014345A3 (en) Antimicrobial peptides isolated from mast cells
ATE26109T1 (en) ACETYLCYSTEINE SALTS, THEIR PREPARATION AND USE.

Legal Events

Date Code Title Description
0001 Granted